Race and technology: study tests better prostate cancer detection
NCT ID NCT03234556
Summary
This study compares two methods for finding serious prostate cancer in men with elevated PSA levels. Researchers want to see if using MRI scans to guide biopsies works better than the standard random biopsy approach. The study specifically includes both African American and white men to understand if detection methods work equally well across different racial groups.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH STATUS UNKNOWN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henry Ford Hospital Vattikuti Urology Institute
Detroit, Michigan, 48202, United States
-
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
University of Maryland
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.